Johnson & Johnson's McNeil Consumer Products subsidiary the world's leading maker of over-the-counter pain relievers, agreed to revise the labelling of its Tylenol brand to warn about possible liver damage if the recommended dose is exceeded by "chronic heavy alcohol users". Previous labelling did not specifically warn about organ damage.